The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome

Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radio...

Full description

Bibliographic Details
Main Authors: Yu-Jung Lin, Yu-Wen Hu, Nae-Fang Twu, Yu-Ming Liu
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455919301603
_version_ 1819168389164171264
author Yu-Jung Lin
Yu-Wen Hu
Nae-Fang Twu
Yu-Ming Liu
author_facet Yu-Jung Lin
Yu-Wen Hu
Nae-Fang Twu
Yu-Ming Liu
author_sort Yu-Jung Lin
collection DOAJ
description Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radiotherapy and determine predictors for loco-regional recurrence or development of distant metastasis. Materials and methods: A retrospective medical records review was performed on patients with surgical stage I endometrial cancer treated at Taipei Veterans General Hospital between 2006 and 2013. Multivariable analysis was conducted using Cox regression for prognostic predictors. Results: A total of 337 patients were identified. The estimated five-year overall survival and loco-regional recurrence-free survival were 96.3% and 97.9% in the non-radiotherapy group, and 91.6% and 97.1% in the radiotherapy group (p = 0.06 overall survival, p = 0.956 loco-regional recurrence-free survival). Multivariable analysis revealed that elevated preoperative serum Cancer Antigen 125 (CA-125) level (hazard ratio (HR) = 2.54), age older than 60 years old (HR = 3.34), and depth of myometrial invasion > 50% (HR = 3.37) were significant factors in overall survival. Elevated preoperative CA-125 level (HR = 5.37), age older than 60 years (HR = 6.57), positive lymphovascular space invasion (HR = 50.20), and adjuvant radiotherapy (HR = 0.05) were independent predictors of loco-regional recurrence-free survival. For distant metastasis, deep myometrial invasion was a significant risk factor. Conclusions: Postoperative radiotherapy delivery is an independent predictor for loco-regional recurrence-free survival but has no impact on overall survival in this population. Preoperative CA-125 level is a risk factor for loco-regional recurrence, and deep myometrial invasion was correlated with distant metastasis. Keywords: Endometrial neoplasms, Radiotherapy, Adjuvant
first_indexed 2024-12-22T19:02:49Z
format Article
id doaj.art-3f5bed305dbb491fa42d848064b85dcb
institution Directory Open Access Journal
issn 1028-4559
language English
last_indexed 2024-12-22T19:02:49Z
publishDate 2019-09-01
publisher Elsevier
record_format Article
series Taiwanese Journal of Obstetrics & Gynecology
spelling doaj.art-3f5bed305dbb491fa42d848064b85dcb2022-12-21T18:15:53ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592019-09-01585604609The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcomeYu-Jung Lin0Yu-Wen Hu1Nae-Fang Twu2Yu-Ming Liu3Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC; National Yang-Ming University, Taipei, Taiwan, ROCDivision of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROCDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan, ROCDivision of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC; National Yang-Ming University, Taipei, Taiwan, ROC; Corresponding author. Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec.2, Shipai Rd., Taipei City, 11217, Taiwan, ROC. Fax: +886 2 28749425.Objective: Postoperative radiotherapy for early endometrial cancer has been investigated in several randomized trials. These trials demonstrate that it reduces loco-regional recurrence, but has no impact on overall survival. The aims of this study were to better understand the role of adjuvant radiotherapy and determine predictors for loco-regional recurrence or development of distant metastasis. Materials and methods: A retrospective medical records review was performed on patients with surgical stage I endometrial cancer treated at Taipei Veterans General Hospital between 2006 and 2013. Multivariable analysis was conducted using Cox regression for prognostic predictors. Results: A total of 337 patients were identified. The estimated five-year overall survival and loco-regional recurrence-free survival were 96.3% and 97.9% in the non-radiotherapy group, and 91.6% and 97.1% in the radiotherapy group (p = 0.06 overall survival, p = 0.956 loco-regional recurrence-free survival). Multivariable analysis revealed that elevated preoperative serum Cancer Antigen 125 (CA-125) level (hazard ratio (HR) = 2.54), age older than 60 years old (HR = 3.34), and depth of myometrial invasion > 50% (HR = 3.37) were significant factors in overall survival. Elevated preoperative CA-125 level (HR = 5.37), age older than 60 years (HR = 6.57), positive lymphovascular space invasion (HR = 50.20), and adjuvant radiotherapy (HR = 0.05) were independent predictors of loco-regional recurrence-free survival. For distant metastasis, deep myometrial invasion was a significant risk factor. Conclusions: Postoperative radiotherapy delivery is an independent predictor for loco-regional recurrence-free survival but has no impact on overall survival in this population. Preoperative CA-125 level is a risk factor for loco-regional recurrence, and deep myometrial invasion was correlated with distant metastasis. Keywords: Endometrial neoplasms, Radiotherapy, Adjuvanthttp://www.sciencedirect.com/science/article/pii/S1028455919301603
spellingShingle Yu-Jung Lin
Yu-Wen Hu
Nae-Fang Twu
Yu-Ming Liu
The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
Taiwanese Journal of Obstetrics & Gynecology
title The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
title_full The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
title_fullStr The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
title_full_unstemmed The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
title_short The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
title_sort role of adjuvant radiotherapy in stage i endometrial cancer a single institution outcome
url http://www.sciencedirect.com/science/article/pii/S1028455919301603
work_keys_str_mv AT yujunglin theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT yuwenhu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT naefangtwu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT yumingliu theroleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT yujunglin roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT yuwenhu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT naefangtwu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome
AT yumingliu roleofadjuvantradiotherapyinstageiendometrialcancerasingleinstitutionoutcome